(Q57320364)

English

Redirection of T cells with a first fully humanized bispecific CD33–CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells

article by C Arndt et al published 17 January 2013 in Leukemia

In more languages

Statements

scholarly article

0 references

Redirection of T cells with a first fully humanized bispecific CD33–CD3 antibody efficiently eliminates AML blasts without harming hematopoietic stem cells (English)

0 references

1 reference

based on heuristic

inferred from title

Marc Cartellieri

object named as

M Cartellieri

3

0 references

Gerhard Ehninger

10

object named as

G Ehninger

0 references

Martin Bornhäuser

8

object named as

M Bornhäuser

0 references

author name string

C Arndt

1

0 references

M von Bonin

2

0 references

A Feldmann

4

0 references

S Koristka

5

0 references

I Michalk

6

0 references

S Stamova

7

0 references

M Schmitz

9

0 references

M Bachmann

11

0 references

publication date

17 January 2013

0 references

0 references

27

0 references

4

0 references

964-967

0 references

https://scigraph.springernature.com/pub.10.1038/leu.2013.18

0 references

Current and emerging therapies for acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

21 January 2018

Recent advances in acute myeloid leukemia stem cell biology

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

21 January 2018

Acute myeloid leukemia stem cells and CD33-targeted immunotherapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

21 January 2018

Hematopoietic stem cells express multiple myeloid markers: implications for the origin and targeted therapy of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

21 January 2018

Unexpected recombinations in single chain bispecific anti-CD3-anti-CD33 antibodies can be avoided by a novel linker module

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

21 January 2018

Retargeting of human regulatory T cells by single-chain bispecific antibodies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

21 January 2018

In Vitro and In Vivo Antitumor Effect of Anti-CD33 Chimeric Receptor-Expressing EBV-CTL against CD33 Acute Myeloid Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

21 January 2018

Hematopoietic stem cells in co-culture with mesenchymal stromal cells--modeling the niche compartments in vitro.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

21 January 2018

Expression of the target receptor CD33 in CD34+/CD38-/CD123+ AML stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

7 January 2021

based on heuristic

inferred from DOI database lookup

T lymphocytes can be effectively recruited for ex vivo and in vivo lysis of AML blasts by a novel CD33/CD3-bispecific BiTE antibody construct.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Simultaneous engagement of the activatory receptors NKG2D and CD3 for retargeting of effector cells to CD33-positive malignant cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Novel humanized and highly efficient bispecific antibodies mediate killing of prostate stem cell antigen-expressing tumor cells by CD8+ and CD4+ T cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2013.18

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2013.18

0 references

PubMed publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q57320364&oldid=1554411716"